Bladder Cancer Breakthrough: 82% CR Rate?!

TAR-200 is seriously shaking up the bladder cancer world! In the latest SunRISe-1 study, patients with tough-to-treat bladder cancer saw an insane 82.4% complete response rate—and the results actually lasted, with over half still in remission after a year. Even better, most people handled the treatment well, with only mild side effects for the majority. This could be a game-changer for those out of options! #BladderCancer #MedicalBreakthrough #CancerResearch #TAR200 #ClinicalTrials #Health